About 3 results found for searched term "Ceftobiprole" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M29688 | Ceftobiprole medocaril sodium | Antibiotic |
| BAL5788 sodium | ||
| Ceftobiprole medocaril (BAL5788) sodium is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M30013 | Ceftobiprole medocaril | Antibiotic |
| BAL5788 | ||
| Ceftobiprole medocaril (BAL5788) is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M54693 | Ceftobiprole | Antibiotic |
| Ro 63-9141; BAL 9141 | ||
| Ceftobiprole is a broad-spectrum cephalosporin with rapid bactericidal activity against Gram-positive bacteria such as Staphylococcus aureus, including methicillin-resistant strains (MRSA), and Gram-negative bacteria, with a MIC90 value of 2 μg/mL against MRSA. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
